scispace - formally typeset
G

Gaurav Swarnkar

Researcher at Washington University in St. Louis

Publications -  43
Citations -  1197

Gaurav Swarnkar is an academic researcher from Washington University in St. Louis. The author has contributed to research in topics: Osteoclast & Bone remodeling. The author has an hindex of 20, co-authored 40 publications receiving 915 citations. Previous affiliations of Gaurav Swarnkar include Council of Scientific and Industrial Research & Central Drug Research Institute.

Papers
More filters
Journal ArticleDOI

Kaempferol has osteogenic effect in ovariectomized adult Sprague-Dawley rats.

TL;DR: It is shown that K is non-estrogenic in vivo and exerts bone anabolic activity with attendant inhibition of bone marrow adipogenesis, and exhibits no estrogenicity at the uterine level.
Journal ArticleDOI

LDHA-mediated ROS generation in chondrocytes is a potential therapeutic target for osteoarthritis

TL;DR: It is shown that inflammatory NF-κB signalling drives a glycolytic shift in chondrocytes and the production of ROS, which drives cartilage catabolism, which identifies LDHA as a potential therapeutic target for OA treatment.
Journal ArticleDOI

A novel quercetin analogue from a medicinal plant promotes peak bone mass achievement and bone healing after injury and exerts an anabolic effect on osteoporotic bone: The role of aryl hydrocarbon receptor as a mediator of osteogenic action

TL;DR: The data suggest that GTDF stimulates osteoblast growth and differentiation via the AhR and promotes modeling‐directed bone accrual, accelerates bone healing after injury, and exerts anabolic effects on osteopenic rats likely by a direct stimulatory effect on osteoprogenitors.
Journal ArticleDOI

Role of Phytochemicals in the Prevention of Menopausal Bone Loss: Evidence from In Vitro and In Vivo, Human Interventional and Pharmacokinetic Studies

TL;DR: Making analogues of the most potent molecule for developing synthetic series with rational drug design approach could pay rich dividends in menopausal osteoporosis therapy.